Background: To establish an easy and rapid method for evaluating pial collateral flow, we compared the Alberta Stroke Program Early CT Score (ASPECTS) on nonenhanced CT (NECT), conventional contrast-enhanced CT (CECT), and CT angiography source images (CTA-SI) in patients with acute ischemic stroke. Methods: We reviewed 55 consecutive patients with acute ischemic stroke involving the anterior circulation who underwent thrombolysis within 6 h of referral to the stroke center. We evaluated axial images using NECT, CECT and CTA-SI. Pial collateral formation was graded as fair (1–2 points) or bad (3–5 points) based on 4-vessel angiography. The outcomes were dichotomized into good (modified Rankin Scale, mRS 0–2) or poor (mRS 3–6) using a 90-day mRS. Results: Demographics (age, sex, initial National Institutes of Health Stroke Scale score, time to CT acquisition and stroke subtypes) did not significantly differ between patients with fair or bad collateral formation. ASPECTS on CECT (r = –0.788, p < 0.0001) was more inversely correlated with pial collateral formation than ASPECTS on NECT (r = –0.557, p < 0.0001) or ASPECTS on CTA-SI (r = –0.662, p < 0.0001). Furthermore, ASPECTS on CECT demonstrated a high discriminative capability, with an area under the receiver operating characteristic curve of 0.885 for fair collateral circulation, compared to 0.790 for ASPECTS on NECT and 0.794 for ASPECTS on CTA-SI. Multiple regression analysis revealed that ASPECTS on CECT (≧8) was an independent predictor for fair collateral circulation (odds ratio = 23.00, p < 0.001) and a good prognosis (odds ratio = 17.81, p < 0.001). Conclusion: ASPECTS on CECT is a feasible method for predicting pial collateral flow and overall outcomes in acute ischemic stroke.

Keywords:
Computed tomography, Collateral circulation, Acute ischemic stroke
1.
Bang OY, Saver JL, Buck BH, Alger JR, Starkman S, Ovbiagele B, et al: Impact of collateral flow on tissue fate in acute ischaemic stroke. J Neurol Neurosurg Psychiatry 2008;79:625–629.
2.
Liebeskind DS: Collateral circulation. Stroke 2003;34:2279–2284.
3.
Liebeskind DS: Collaterals in acute stroke: beyond the clot. Neuroimaging Clin N Am 2005;15:553–573.
4.
Demchuk AM, Coutts SB: Alberta Stroke Program Early CT Score in acute stroke triage. Neuroimaging Clin N Am 2005;15:409–419.
5.
Aviv RI, Mandelcorn J, Chakraborty S, Gladstone D, Malham S, Tomlinson G, et al: Alberta Stroke Program Early CT Scoring of CT perfusion in early stroke visualization and assessment. AJNR Am J Neuroradiol 2007;28:1975–1980.
6.
Coutts SB, Lev MH, Eliasziw M, Roccatagliata L, Hill MD, Schwamm LH, et al: Aspects on CTA source images versus unenhanced CT: added value in predicting final infarct extent and clinical outcome. Stroke 2004;35:2472–2476.
7.
Schramm P: High-concentration contrast media in neurological multidetector-row CT applications: implications for improved patient management in neurology and neurosurgery. Neuroradiology 2007;49(suppl 1): S35–S45.
8.
Lucka S, Jaouad L, Hasan Y, Karl L, Philippe T, Mario C, et al: Intravenous versus combined (intravenous and intra-arterial) thrombolysis in acute ischemic stroke: a transcranial color-coded duplex sonography-guided pilot study. Stroke 2006;37:1805–1809.
9.
Lee KY, Kim DI, Kim SH, Lee SI, Chung WM, Shim YM, et al: Sequential combination of intravenous recombinant tissue plasminogen activator and intra-arterial urokinase in acute ischemic stroke. AJNR Am J Neuroradiol 2004;25:1470–1475.
10.
Hashem MS, Karen CA, Nicole RG, Raymond UW, Aslam MK, Rebecca MS, et al: Is intra-arterial thrombolysis safe after full-dose intravenous recombinant tissue plasminogen activator for acute ischemic stroke? Stroke 2007;38:80–84.
11.
del Zoppo GJ, Higashida RT, Furlan AJ, Pessin MS, Rowley HA, Gent M: PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. PROACT investigators. Prolyse in acute cerebral thromboembolism. Stroke 1998;29:4–11.
12.
The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings. TIMI study group. N Engl J Med 1985;312:932–936.
13.
Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Meier D, et al: Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Second European-Australasian Acute Stroke Study Investigators. Lancet 1998;352:1245–1251.
14.
Christoforidis GA, Mohammad Y, Kehagias D, Avutu B, Slivka AP: Angiographic assessment of pial collaterals as a prognostic indicator following intra-arterial thrombolysis for acute ischemic stroke. AJNR Am J Neuroradiol 2005;26:1789–1797.
15.
Camargo EC, Furie KL, Singhal AB, Roccatagliata L, Cunnane ME, Halpern EF, et al: Acute brain infarct: detection and delineation with CT angiographic source images versus nonenhanced CT scans. Radiology 2007;244:541–548.
16.
Grond M, Rudolf J, Schneweis S, Terstegge K, Sobesky J, Kracht L, et al: Feasibility of source images of computed tomographic angiography to detect the extent of ischemia in hyperacute stroke. Cerebrovasc Dis 2002;13:251–256.
17.
Matthew BM, Michael HL, Hakan Ay, Aneesh BS, David MG, Wade SS, et al: Collateral vessels on CT angiography predict outcome in acute ischemic stroke. Stroke 2009;40:3001–3005.
18.
Tan IY, Demchuk AM, Hopyan J, Zhang L, Gladstone D, Wong K, et al: CT angiography clot burden score and collateral score: correlation with clinical and radiologic outcomes in acute middle cerebral artery infarct. AJNR Am J Neuroradiol 2009;30:525–531.
19.
Na DG, Byun HS, Lee KH, Chung CS, Kim EY, Ro DW, et al: Acute occlusion of the middle cerebral artery: early evaluation with triphasic helical CT – preliminary results. Radiology 1998;207:113–122.
20.
Lee KH, Cho SJ, Byun HS, Na DG, Choi NC, Lee SJ, et al: Triphasic perfusion computed tomography in acute middle cerebral artery stroke: a correlation with angiographic findings. Arch Neurol 2000;57:990–999.
21.
Lee KH, Lee SJ, Cho SJ, Na DG, Byun HS, Kim YB, et al: Usefulness of triphasic perfusion computed tomography for intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. Arch Neurol 2000;57:1000–1008.
22.
Na DG, Kim EY, Ryoo JW, Lee KH, Roh HG, Kim SS, et al: CT sign of brain swelling without concomitant parenchymal hypoattenuation: comparison with diffusion- and perfusion-weighted MR imaging. Radiology 2005;235:992–948.
23.
Butcher KS, Lee SB, Parsons MW, Allport L, Fink J, Tress B, et al: Differential prognosis of isolated cortical swelling and hypoattenuation on CT in acute stroke. Stroke 2007;38:941–947.
24.
Hunter GJ, Hamberg LM, Ponzo JA, Huang-Hellinger FR, Morris PP, Rabinov J, et al: Assessment of cerebral perfusion and arterial anatomy in hyperacute stroke with three-dimensional functional CT: early clinical results AJNR Am J Neuroradiol 1998;19:29–37.
25.
Miteff F, Levi CR, Bateman GA, Spratt N, McElduff P, Parsons MW: The independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke. Brain 2009;132:2231–2238.
26.
Kucinski T, Koch C, Eckert B, Becker V, Kromer H, Heesen C, et al: Collateral circulation is an independent radiological predictor of outcome after thrombolysis in acute ischaemic stroke. Neuroradiology 2003;45:11–18.
27.
Qureshi AI: New grading system for angiographic evaluation of arterial occlusions and recanalization response to intra-arterial thrombolysis in acute ischemic stroke. Neurosurgery 2002;50:1405–1414.
28.
Christoforidis GA, Karakasis C, Mohammad Y, Caragine LP, Yang M, Slivka AP: Predictors of hemorrhage following intra-arterial thrombolysis for acute ischemic stroke: the role of pial collateral formation. AJNR Am J Neuroradiol 2009;30:165–170.
29.
Reto AM: Imaging viable brain tissue with CT scan during acute stroke. Cerebrovasc Dis 2004;17(suppl 3):28–34.
© 2011 S. Karger AG, Basel
2011
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.